Global Point of Care Cancer Screening Market

Global Point of Care Cancer Screening Market Size, Trends & Analysis - Forecasts to 2026 By Cancer Type (Oral Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Skin Cancer, and Other Cancer Type), By Technology (Fluorescence, Electrical Impedance Spectroscopy, Infrared Thermography, Biophotonic, and Other Technologies), By End User (Home Care, Cancer Specialty Clinics and Hospitals and Cancer Research Organizations), Competitive Landscape Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 17 2024 with the latest and most recent market numbers

Point of Care Cancer Screening Market Insights

Conducting screening tests using point of care or medical imaging devices to localize or diagnose the presence of abnormal cells or tumour cells in patients and potential patients with or without symptoms is called as cancer screening procedure. Early cancer diagnosis leads to better treatment methodology which is less painful and expensive. It also helps the patient to reduce its chances of dying due to cancer last stage detection. Most commonly pre-screened cancer types are oral cancer, breast cancer, cervical cancer and skin cancer. The traditional cancer screening techniques include the use of mammography, ultrasound, CT Scan, MRI, and biopsy in order to detect the presence, type and stage of cancer in the patients. However these methods are time consuming, invasive and costly which rules out patients undergoing such procedure from the low income countries. The diagnosis market has been recently witnessed increasing number of launch of portable and point of care cancer diagnostic devices which are compact user friendly, cost effective, non-invasive to minimally invasive and provide precise diagnosis. Many such start-up firms have been engaged in offering such smart devices which can be used by both home care settings and hospital settings. Some of the notable companies in the market who provide point of care and user friendly cancer screening devices are Check-Cap, Endomagnetics Ltd., MobileODT, UE LifeSciences Inc., GenWorks Health Pvt. Ltd. and Ibex Medical Analytics Ltd. These companies offer devices which are in the form of portable trolley based devices, benchtop devices, devices with connected apps or software to provide real time analysis of tumour location and type. The market for point of care cancer screening devices will be growing rapidly owing to rising cancer cases, increasing awareness regarding cancer screening programs, increasing prevalence of breast cancer in geriatric women population, increasing demand for minimally invasive and cost effective and user friendly devices which can be used at home at patient’s comfort for preliminary screening stage diagnosis. Also, increasing number of upcoming and innovative players in the market to launch portable screening devices have helped the market grow rapidly during the forecast period of 2021 to 2026. However, the awareness regarding early cancer diagnosis, cost constrains and lack of advanced technology available in low income countries will may pose as challenging factors for the market to grow globally.

global point of care cancer screening market

Point of Care Cancer Screening Market: By Cancer Type

Based on the type of cancer, the market of point of cancer screening device is segmented into oral cancer, breast cancer, cervical cancer, colorectal cancer, skin cancer, and other cancer type. However owing to high prevalence of breast cancer and cervical cancer, the segments of breast and cervical will be the largest market segments from 2021 to 2026. As per U.S. Breast Cancer Statistics data, around 1 in every 8 women in the U.S. i.e. around 13-15% of the women population are suspected to develop breast cancer in their lifetime and might have to go through invasive procedures to remove the tumor. Also, more than 281,550 fresh new diagnosis have been recorded in 2021 for invasive breast cancer and around 50,000 new cases for non-invasive or in situ breast cancer type.

Point of Care Cancer Screening Market: By Technology

As per the point of care technology, the market can be segmented into fluorescence, electrical impedance spectroscopy, infrared thermography, biophotonic, and other technologies. The fluorescence technology will bag the largest marketshare from 2021 to 2026. The fluorescence technology has become one of the most promising and supportive technology in terms of cancer screening and surveillance procedure. Also, as per clinicaltrials.gov, there are more than 30 listed projects which are related to fluorescence technology for cancer screening. This segment will also be the fastest growing segment in the market from 2021 to 2026.

Point of Care Cancer Screening Market: By End-User

The potential users of these innovative products in the market are home care, cancer specialty clinics and hospitals, and cancer research organizations. The cancer specialty clinics and hospitals segment will be the dominant segment in the market owing to increasing patient admission in hospitals and clinics for pre-stage cancer screening programs. The home care setting will be the fastest growing segment considering the user friendly nature of the product and the future of point of care medical devices where patients can screen themselves sitting at home and help diagnose possible tumours are a very early stage.

asia pacific point of care cancer screening market

Point of Care Cancer Screening Market: By Region

As per the geographical analysis, the Point of Care Cancer Screening Market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central & South America (Brazil, Argentina, and Rest of Central and South America). North America (the United States, Canada, and Mexico) will be the market segment with a lion’s share. The high awareness and favourable reimbursement rules for cancer screening tests and devices in North America have helped the region bag the dominant position in the global market. Also, presence of the top innovative start-ups in the US has also promoted this dominant growth of North American region in the market. One the other hand, increasing cancer cases in Asian countries will help the Asia Pacific region grow the fastest.

Point of Care Cancer Screening Market Share and Competitor Analysis

AdDent, Forward Science, LED Apteryx Inc., Breastlight, Zilico, Braster S.A., Bremed Ltd., TruScreen, Niramai Health Analytics, Guided Therapeutics, LED Dental, PWB Health, Sascan, Lightpoint Medical, Check-Cap, Endomagnetics Ltd., MobileODT, UE LifeSciences Inc., GenWorks Health Pvt. Ltd. and Ibex Medical Analytics Ltd are the key players in the point of care cancer screening market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Point of Care Cancer Screening Industry Overview, 2016-2026

2.1.1 Industry Overview

2.1.2 Cancer Type Overview

2.1.3 Technology Overview

2.1.4 End-User Overview

2.1.6 Regional Overview

Chapter 3 Point of Care Cancer Screening Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2016-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Rising prevalence of cancer cases especially breast and cervical cancer

3.3.1.2 Rising awareness regarding painless smart and minimally invasive screening device

3.3.2 Industry Challenges

3.3.2.1 Lack of adequate knowledge and awareness regarding pre-stage cancer screening techniques

3.4 Prospective Growth Scenario

3.4.1 Cancer Type Growth Scenario

3.4.2 Technology Growth Scenario

3.4.3 End-User Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 End-User Overview

3.11 Market Share Analysis, 2020

3.11.1 Company Positioning Overview, 2020

Chapter 4 Point of Care Cancer Screening Market, By Cancer Type

4.1 Cancer Type Outlook

4.2 Oral Cancer

4.2.1 Market Size, By Region, 2016-2026 (USD Million)

4.3 Breast Cancer

4.3.1 Market Size, By Region, 2016-2026 (USD Million)

4.4 Cervical Cancer

4.4.1 Market Size, By Region, 2016-2026 (USD Million)

4.5 Colorectal Cancer

4.5.1 Market Size, By Region, 2016-2026 (USD Million)

4.6 Skin Cancer

4.6.1 Market Size, By Region, 2016-2026 (USD Million)

Chapter 5 Point of Care Cancer Screening Market, By Technology

5.1 Technology Outlook

5.2 Fluorescence

5.2.1 Market Size, By Region, 2016-2026 (USD Million)

5.3 Electrical Impedance Spectroscopy

5.3.1 Market Size, By Region, 2016-2026 (USD Million)

5.4 Infrared Thermography

5.4.1 Market Size, By Region, 2016-2026 (USD Million)

5.5 Biophotonic

5.5.1 Market Size, By Region, 2016-2026 (USD Million)

Chapter 6 Point of Care Cancer Screening Market, By End-User

6.1 Home Care

6.1.1 Market Size, By Region, 2016-2026 (USD Million)

6.2 Cancer Specialty Clinics and Hospitals

6.2.1 Market Size, By Region, 2016-2026 (USD Million)

6.3 Cancer Research Organizations

6.3.1 Market Size, By Region, 2016-2026 (USD Million)

Chapter 8 Point of Care Cancer Screening Market, By Region

8.1 Regional outlook

8.2 North America

8.2.1 Market Size, By Country 2016-2026 (USD Million)

8.2.2 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.2.3 Market Size, By Technology, 2016-2026 (USD Million)

8.2.4 Market Size, By End-User, 2016-2026 (USD Million)

8.2.6 U.S.

8.2.6.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.2.4.2 Market Size, By Technology, 2016-2026 (USD Million)

8.2.4.3 Market Size, By End-User, 2016-2026 (USD Million)

8.2.7 Canada

8.2.7.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.2.7.2 Market Size, By Technology, 2016-2026 (USD Million)

8.2.7.3 Market Size, By End-User, 2016-2026 (USD Million)

8.3 Europe

8.3.1 Market Size, By Country 2016-2026 (USD Million)

8.3.2 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.3.3 Market Size, By Technology, 2016-2026 (USD Million)

8.3.4 Market Size, By End-User, 2016-2026 (USD Million)

8.3.6 Germany

8.3.6.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.3.6.2 Market Size, By Technology, 2016-2026 (USD Million)

8.3.6.3 Market Size, By End-User, 2016-2026 (USD Million)

8.3.7 UK

8.3.7.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.3.7.2 Market Size, By Technology, 2016-2026 (USD Million)

8.3.7.3 Market Size, By End-User, 2016-2026 (USD Million)

8.3.8 France

8.3.8.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.3.8.2 Market Size, By Technology, 2016-2026 (USD Million)

8.3.8.3 Market Size, By End-User, 2016-2026 (USD Million)

8.3.9 Italy

8.3.9.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.3.9.2 Market Size, By Technology, 2016-2026 (USD Million)

8.3.9.3 Market Size, By End-User, 2016-2026 (USD Million)

8.3.10 Spain

8.3.10.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.3.10.2 Market Size, By Technology, 2016-2026 (USD Million)

8.3.10.3 Market Size, By End-User, 2016-2026 (USD Million)

8.3.11 Russia

8.3.11.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.3.11.2 Market Size, By Technology, 2016-2026 (USD Million)

8.3.11.3 Market Size, By End-User, 2016-2026 (USD Million)

8.4 Asia Pacific

8.4.1 Market Size, By Country 2016-2026 (USD Million)

8.4.2 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.4.3 Market Size, By Technology, 2016-2026 (USD Million)

8.4.4 Market Size, By End-User, 2016-2026 (USD Million)

8.4.6 China

8.4.6.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.4.6.2 Market Size, By Technology, 2016-2026 (USD Million)

8.4.6.3 Market Size, By End-User, 2016-2026 (USD Million)

8.4.7 India

8.4.7.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.4.7.2 Market Size, By Technology, 2016-2026 (USD Million)

8.4.7.3 Market Size, By End-User, 2016-2026 (USD Million)

8.4.8 Japan

8.4.8.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.4.8.2 Market Size, By Technology, 2016-2026 (USD Million)

8.4.8.3 Market Size, By End-User, 2016-2026 (USD Million)

8.4.9 Australia

8.4.9.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.4.9.2 Market size, By Technology, 2016-2026 (USD Million)

8.4.9.3 Market Size, By End-User, 2016-2026 (USD Million)

8.4.10 South Korea

8.4.10.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.4.10.2 Market Size, By Technology, 2016-2026 (USD Million)

8.4.10.3 Market Size, By End-User, 2016-2026 (USD Million)

8.5 Latin America

8.5.1 Market Size, By Country 2016-2026 (USD Million)

8.5.2 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.5.3 Market Size, By Technology, 2016-2026 (USD Million)

8.5.4 Market Size, By End-User, 2016-2026 (USD Million)

8.5.6 Brazil

8.5.6.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.5.6.2 Market Size, By Technology, 2016-2026 (USD Million)

8.5.6.3 Market Size, By End-User, 2016-2026 (USD Million)

8.5.7 Mexico

8.5.7.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.5.7.2 Market Size, By Technology, 2016-2026 (USD Million)

8.5.7.3 Market Size, By End-User, 2016-2026 (USD Million)

8.5.8 Argentina

8.5.8.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.5.8.2 Market Size, By Technology, 2016-2026 (USD Million)

8.5.8.3 Market Size, By End-User, 2016-2026 (USD Million)

8.6 MEA

8.6.1 Market Size, By Country 2016-2026 (USD Million)

8.6.2 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.6.3 Market Size, By Technology, 2016-2026 (USD Million)

8.6.4 Market Size, By End-User, 2016-2026 (USD Million)

8.6.6 Saudi Arabia

8.6.6.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.6.6.2 Market Size, By Technology, 2016-2026 (USD Million)

8.6.6.3 Market Size, By End-User, 2016-2026 (USD Million)

8.6.7 UAE

8.6.7.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.6.7.2 Market Size, By Technology, 2016-2026 (USD Million)

8.6.7.3 Market Size, By End-User, 2016-2026 (USD Million)

8.6.8 South Africa

8.6.8.1 Market Size, By Cancer Type, 2016-2026 (USD Million)

8.6.8.2 Market Size, By Technology, 2016-2026 (USD Million)

8.6.8.3 Market Size, By End-User, 2016-2026 (USD Million)

Chapter 9 Company Landscape

9.1 Competitive Analysis, 2020

9.2 AdDent

9.2.1 Company Overview

9.2.2 Financial Analysis

9.2.3 Strategic Positioning

9.2.4 Info Graphic Analysis

9.3 Forward Science

9.3.1 Company Overview

9.3.2 Financial Analysis

9.3.3 Strategic Positioning

9.3.4 Info Graphic Analysis

9.4 LED Apteryx Inc.

9.4.1 Company Overview

9.4.2 Financial Analysis

9.4.3 Strategic Positioning

9.4.4 Info Graphic Analysis

9.5 Breastlight

9.5.1 Company Overview

9.5.2 Financial Analysis

9.5.3 Strategic Positioning

9.5.4 Info Graphic Analysis

9.6 Zilico, Braster S.A.

9.6.1 Company Overview

9.6.2 Financial Analysis

9.6.3 Strategic Positioning

9.6.4 Info Graphic Analysis

9.7 Bremed Ltd.

9.7.1 Company Overview

9.7.2 Financial Analysis

9.7.3 Strategic Positioning

9.7.4 Info Graphic Analysis

9.8 TruScreen

9.8.1 Company Overview

9.8.2 Financial Analysis

9.8.3 Strategic Positioning

9.8.4 Info Graphic Analysis

9.9 Niramai Health Analytics

9.9.1 Company Overview

9.9.2 Financial Analysis

9.9.3 Strategic Positioning

9.9.4 Info Graphic Analysis

9.10 PWB Health

9.10.1 Company Overview

9.10.2 Financial Analysis

9.10.3 Strategic Positioning

9.10.4 Info Graphic Analysis

9.11 Other Companies

9.11.1 Company Overview

9.11.2 Financial Analysis

9.11.3 Strategic Positioning

9.11.4 Info Graphic Analysis

The Global Point of Care Cancer Screening Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Point of Care Cancer Screening Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global point of care cancer screening market?

The global point of care cancer screening market size is projected to grow CAGR value of 7.8% between 2021 to 2026.

Who are the major vendors in the point of care cancer screening market?

Key and innovative vendors in the point of care cancer screening market include AdDent, Forward Science, LED Apteryx Inc., Breastlight, Zilico, Braster S.A., Bremed Ltd., TruScreen, Niramai Health Analytics, Guided Therapeutics, LED Dental, PWB Health, Sascan, Lightpoint Medical, and Check-Cap, among others.

Which region has the highest market share in the point of care cancer screening market?

The North American region is estimated to hold the largest share of the point of care cancer screening market.

What is the Covid-19 impact on future point of care cancer screening manufacturers?

The COVID-19 pandemic has increased the stress on healthcare facilities. With healthcare providers being overwhelmed by the sheer number of COVID cases, regular screenings, and check-ups have had to be postponed and delayed. Projects to implement new point of care cancer screening products were shelved in favour of meeting the demands of the pandemic. The market is expected to bounce back during the forecast period.

What are the major drivers in the point of care cancer screening market?

The growing investment in drug discovery, the growing number of people suffering from bone-related diseases, expanding pharmaceutical manufacturing capabilities, and the growing geriatric population across the globe are the major drivers of the point of care cancer screening market.